Anticancer and Apoptotic Effect of Alogliptin on A549 Cancer Cell Line
Wiadomości Lekarskie · 27.02.2026 · (2) · 346-354
DOI: 10.36740/wlek/217851 ↗Kurz gefasst
Fachartikel in der Zeitschrift Wiadomości Lekarskie, online erschienen am 27.02.2026. Verfasst von Safa Hussien Radhi Abbas und 1 weiteren Autor:innen. Beteiligte Einrichtung: DEPARTMENT OF PHARMACOLOGY AND TOXICOLOGY, FACULTY OF PHARMACY, UNIVERSITY OF KUFA, NAJAF, IRAQ. Hauptthemen laut MEDLINE: Apoptosis, Piperidines, Lung Neoplasms, Uracil.
Abstract (Originalsprache)
Aim
Background: Lung cancer is one of the primary causes of cancer-related death. The effectiveness of current treatments is frequently hampered by side effects, medication resistance. Dipeptidyl peptidase-4 (DPP-4) inhibitors, which are mainly used to treat diabetes, have shown promising anticancer properties in a variety of cancer types.
Aim
To evaluate the anticancer, apoptotic, and antioxidant effects of Alo on A549 cells, both alone and in combination with CP, and to elucidate the molecular mechanisms underlying the death of cancer cells. Material and methods Materials & Methods: The American Type Culture Collection's (ATCC) normal HBL100 cells and human lung A549 cells were used in the investigation. The cells were split into four groups. Following a 72-hour incubation period, ELISA assays were used to quantify the levels of the DPP-4 enzyme, apoptotic regulators (Bax and caspase-3), and oxidative stress marker (malondialdehyde) in lung cancer cell and normal cell lines. One-way ANOVA with significance set at P < 0.05 were used in the statistical analysis.
Results
Results: The findings showed that Alo reduced the activity of the DPP-4 enzyme in both cell lines (P < 0.0001). Molecular analysis showed a considerable increase in pro-apoptotic markers (BAX, Caspase-3). Higher amounts of malondialdehyde were indicative of increased oxidative stress in both monotherapy and combination. But in HBL 100 cells, Alo decreased BAX, caspase-3, and MDA levels.
Conclusions
Conclusion: Alo has caused cancer cell death through a variety of mechanisms, such as DPP4 inhibition, apoptotic pathway activation, and oxidative stress enhancement based on DPP-4, BAX, caspase-3, and MDA measurements.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- DEPARTMENT OF PHARMACOLOGY AND TOXICOLOGY, FACULTY OF PHARMACY, UNIVERSITY OF KUFA, NAJAF, IRAQ.
Zitieren
APA
Abbas, S. H. R., & Bairam, A. F. (2026). Anticancer and Apoptotic Effect of Alogliptin on A549 Cancer Cell Line. Wiadomości Lekarskie, 346-354. https://doi.org/10.36740/wlek/217851
Vancouver
Abbas SHR, Bairam AF. Anticancer and Apoptotic Effect of Alogliptin on A549 Cancer Cell Line. Wiadomości Lekarskie. 2026:346-354. doi:10.36740/wlek/217851
BibTeX
@article{Abbas2026,
author = {Abbas, Safa Hussien Radhi and Bairam, Ahsan F},
title = {Anticancer and Apoptotic Effect of Alogliptin on A549 Cancer Cell Line},
journal = {Wiadomości Lekarskie},
year = {2026},
number = {2},
pages = {346--354},
doi = {10.36740/wlek/217851}
}
EUVIMED